Mirena 52 MG systems
Ended Awarded Last action
- Contract number
- SPE2DR26FRFJ9
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,190
Award facts
- Contract value 100% obligated
- $2,189.92 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $2,189.92 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for Mirena 52 mg contraceptive systems. The award was issued on January 28, 2026, with an ultimate completion date of February 19, 2026, and utilized no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy that authorizes the contractor to supply a broad range of pharmaceutical products and medical consumables to Department of Defense healthcare facilities.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, with substantial contracting activity through the DLA's Medical Supply Chain division. The company's product portfolio encompasses branded and generic prescription medications, biologics, vaccines, specialty pharmaceuticals, and medical consumables, positioning it to serve the diverse and specialized pharmaceutical requirements of military healthcare operations globally. As a PPV-G GEN V prime vendor under a contract with a $499.999 billion ceiling and completion date of December 31, 2036, the contractor supports recurring medical supply needs across Department of Defense facilities with firm fixed-price delivery orders for products spanning oncology treatments, immunosuppressants, emergency medications, and routine pharmaceuticals.
Quick answers
Who was awarded contract SPE2DR26FRFJ9?
SPE2DR26FRFJ9 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FRFJ9 worth?
The government has obligated $2,190 on SPE2DR26FRFJ9.
Is contract SPE2DR26FRFJ9 an order under another contract?
Yes. SPE2DR26FRFJ9 is a delivery order under SPE2DR25D9203, an indefinite delivery contract.
Was contract SPE2DR26FRFJ9 competed?
The extent of competition for SPE2DR26FRFJ9 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award